Recombinant monoclonal antibodies and enzymes
Total Trials
6
As Lead Sponsor
5
As Collaborator
1
Total Enrollment
284
NCT01910376
Cancer in Nursing Home Residents
Phase: N/A
Role: Collaborator
Start: Oct 31, 2014
Completion: Dec 31, 2017
NCT03097341
Safety and Tolerability Study of Xisomab 3G3 in Healthy Adult Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 5, 2017
Completion: Jan 16, 2018
NCT03219359
Autologous Stem Cell Transplant for Crohn's Disease
Phase: Phase 2
Start: Jul 12, 2017
Completion: Apr 30, 2026
NCT03453060
Safety and Tolerability Study of E-WE Thrombin in Healthy Adult Subjects
Start: May 30, 2018
Completion: Nov 25, 2018
NCT03612856
Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis
Start: Oct 29, 2018
Completion: Jul 6, 2019
NCT03963895
Safety and Efficacy Study of AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic Hemodialysis
Start: Jul 3, 2019
Completion: Dec 29, 2020
Loading map...